Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Peter C. Dau"'
Autor:
Susan F. Leitman, Kevin Graham, Peter C. Dau, Sheryl F. Kelsey, Jonathan L. Isaacsohn, Peter H. Jones, Evan A. Stein, Bruce R. Gordon, Stuart D. Saal, August J. Troendle, Thomas N. Stern, Robert J. Zwiener, Antonio M. Gotto, D. Roger Illingworth
Publikováno v:
The American Journal of Cardiology. 81:407-411
The short-term effectiveness of low-density lipoprotein (LDL) apheresis using a dextran sulfate cellulose adsorption column technique was previously examined in a 9-center, 22-week controlled trial in 64 patients with familial hypercholesterolemia (F
Autor:
Peter C. Dau
Publikováno v:
Transfusion Science. 17:235-244
The application of therapeutic plasmapheresis (TP) to an autoimmune disease is made with careful attention to immunological mechanisms in the underlying disease process, its tempo, and its severity in the individual patient. The initial volume and fr
Autor:
Peter C. Dau
Publikováno v:
Journal of Neuroimmunology. 62:197-200
It has been difficult to study antibody synthesis in vivo following plasma exchange (PE) because of the intra- and extravascular compartmentation of immunoglobulins, and their altered lymphatic flow and catabolism after the procedure. There is fragme
Autor:
Antonio M. Gotto, Evan A. Stein, David C. Brown, David W. Bilheimer, James S. Prihoda, Bruce R. Gordon, Peter H. Jones, James H. Zavoral, Sheryl F. Kelsey, Susan F. Leitman, Thomas N. Stern, Robert J. Zwiener, Peter C. Dau, D. Roger Illingworth
Publikováno v:
The American Journal of Cardiology. 70:1010-1016
A subgroup of patients with familial hypercholesterolemia (FH) respond inadequately to standard diet and drug therapy, and are therefore at high risk for the premature development or progression of coronary artery disease. This study evaluated low-de
Autor:
William F. Clark, Peter C. Dau, Hans H. Euler, Loïc Guillevin, Joerg Hasford, Andreas H. Heer, J. Verrier Jones, Michael Kashgarian, Genell Knatterud, C. Martin Lockwood, Charles D. Pusey, Gérard Rifle, John A. Robinson, Johann O. Schroeder, Eng M. Tan, Daniel J. Wallace, Steven R. Weiner
Publikováno v:
Journal of Clinical Apheresis. 6:40-47
A group of clinics are collaborating in the Lupus Plasmapheresis Study Group (LPSG) to investigate whether repeated plasmapheresis prior to pulse cyclophosphamide improves the therapeutical results in severe systemic lupus erythematosus (SLE). The un
Autor:
Peter C. Dau
Publikováno v:
Journal of Clinical Apheresis. 6:200-204
Publikováno v:
Journal of immunological methods. 187(1)
The length distributions of the third complementarity determining region (CDR3) of the T cell receptor (TCR) beta chain were determined quantitatively from peripheral blood lymphocytes of healthy donors. RT-PCR products of 26 V beta families and subf
Autor:
Michael J. Vonesh, Cesar J. Herrera, David J. Mehlman, Peter C. Dau, Neil J. Stone, Paul F. DeFrino, James V. Talano, Lee J. Frazin, David D. McPherson
Publikováno v:
Arteriosclerosis and thrombosis : a journal of vascular biology. 14(11)
We explored the concept that transesophageal echocardiography can be used as a tool to detect, characterize, and study plaque morphology in the descending thoracic aorta. The pattern of atherosclerotic plaques in the descending thoracic aorta in fami
Autor:
Peter C. Dau, James P. Callahan
Publikováno v:
Clinical immunology and immunopathology. 70(2)
Immunologic effects of our previously reported treatment protocol were determined in eight systemic sclerosis (SSc) patients treated with plasmapheresis, cyclophosphamide, and prednisone as tolerated. Prior to treatment total serum IgG and circulatin
Autor:
Peter C. Dau
Publikováno v:
Journal of clinical apheresis. 9(1)
Immunologic studies were carried out in a patient with polymyositis (PM), who showed increasing muscle strength and decreasing serum creatine phosphokinase levels during 20 weeks of treatment with plasmapheresis in conjunction with prednisone and cyc